Literature DB >> 15028848

Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein.

H A Alhadi1, K A A Fox.   

Abstract

Heart fatty-acid-binding protein (FABP) is a small cytosolic protein that is abundant in the heart and has low concentrations in the blood and in tissues outside the heart. It appears in the blood as early as 1.5 h after onset of symptoms of infarction, peaks around 6 h and returns to baseline values in 24 h. These features of H-FABP make it an excellent potential candidate for the detection of acute myocardial infarction (AMI). We review the strengths and weaknesses of H-FABP as a clinically applicable marker of myocyte necrosis in the context of acute coronary syndromes.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15028848     DOI： 10.1093/qjmed/hch037

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


  33 in total

1.  Comparison of Warm Blood Cardioplegia Delivery With or Without the Use of a Roller Pump.

Authors:  Mizja M Faber; Peter G Noordzij; Simon Hennink; Hans Kelder; Roel de Vroege; Frans G Waanders; Edgar Daeter; Marco C Stehouwer
Journal:  J Extra Corpor Technol       Date:  2015-12

2.  Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes.

Authors:  Umut Cavus; Figen Coskun; Bunyamin Yavuz; Orcun Ciftci; Levent Sahiner; Hakan Aksoy; Ali Deniz; Engin Ozakin; Kudret Aytemir; Lale Tokgozoglu; Giray Kabakci
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

3.  Comparative study of high sensitivity troponin T and heart-type fatty acid-binding protein in STEMI patients.

Authors:  Shaheena Banu; Syed Tanveer; C N Manjunath
Journal:  Saudi J Biol Sci       Date:  2014-06-10       Impact factor: 4.219

4.  Heart-Type Fatty Acid-Binding Protein, in Early Detection of Acute Myocardial Infarction: Comparison with CK-MB, Troponin I and Myoglobin.

Authors:  Anand K Pyati; Basavaraj B Devaranavadagi; Sanjeev L Sajjannar; Shashikant V Nikam; Mohd Shannawaz; Satish Patil
Journal:  Indian J Clin Biochem       Date:  2016-01-13

5.  Serum heart-type fatty acid binding protein levels in acromegaly patients.

Authors:  M Ozbek; M Erdogan; M Dogan; E Akbal; M A Ozturk; K Ureten
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

6.  Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.

Authors:  Neelima Singh; Vedika Rathore; Roshan Kumar Mahat; Puneet Rastogi
Journal:  Indian J Clin Biochem       Date:  2017-08-03

7.  Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values.

Authors:  Cui Liyan; Zhang Jie; Hu Xiaozhou
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

8.  Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome.

Authors:  Burcu Oktay; Erdem Akbal; Hikmet Firat; Sadik Ardic; Ramazan Akdemir; Murat Kizilgun
Journal:  Sleep Breath       Date:  2008-01-19       Impact factor: 2.816

9.  Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction.

Authors:  Aysun Toker; Alpay Aribas; F Hümeyra Yerlikaya; Erkan Tasyurek; Kürşat Akbuğa
Journal:  J Clin Lab Anal       Date:  2013-02-11       Impact factor: 2.352

10.  Thrombolysis in patients with pulmonary embolism and elevated heart-type fatty acid-binding protein levels.

Authors:  Enes Elvin Gul; Ilknur Can; Mehmet Kayrak; Turyan Abdulhalikov; Halil Ibrahim Erdogan; Gokhan Altunbas; Kurtulus Ozdemir; Hasan Gok
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.